C33H51N3O3 — CID 169312457
(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[(3S)-3-(1-methylpyrazol-4-yl)oxypiperidin-1-yl]pentan-1-one (PubChem CID 169312457) has the molecular formula C33H51N3O3 and a molecular weight of 537.79 g/mol. Its IUPAC name is (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[(3S)-3-(1-methylpyrazol-4-yl)oxypiperidin-1-yl]pentan-1-one.
| Compound Name | (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[(3S)-3-(1-methylpyrazol-4-yl)oxypiperidin-1-yl]pentan-1-one |
|---|---|
| PubChem CID | 169312457 |
| Molecular Formula | C33H51N3O3 |
| Molecular Weight | 537.79 g/mol |
| Exact Mass | 537.39 |
| IUPAC Name | (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[(3S)-3-(1-methylpyrazol-4-yl)oxypiperidin-1-yl]pentan-1-one |
| SMILES | C[C@H](CCC(=O)N1CCC[C@H](Oc2cnn(C)c2)C1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |
| InChI | InChI=1S/C33H51N3O3/c1-22(7-12-31(38)36-17-5-6-25(21-36)39-26-19-34-35(4)20-26)28-10-11-29-27-9-8-23-18-24(37)13-15-32(23,2)30(27)14-16-33(28,29)3/h8,19-20,22,24-25,27-30,37H,5-7,9-18,21H2,1-4H3/t22-,24+,25+,27+,28-,29+,30+,32+,33-/m1/s1 |
| InChIKey | DPEAOYNTWKIVIZ-LKWPGEPWSA-N |
| XLogP | 6.15 |
| TPSA | 67.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.79 |
| LogP ≤ 5 | 6.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|